Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01206452 · ClinicalTrials.gov registry record · Phase 4
Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes
A Phase 4 study, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT01206452 is a Phase 4 study that has completed, run by Dhanunjaya Lakkireddy, MD, FACC. The registered enrollment target is 60 participants.
The verdict
NCT01206452, a Phase 4 study, has completed, sponsored by Dhanunjaya Lakkireddy, MD, FACC.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
Interventions
- OTHER Placebo
- DRUG Prednisone
- PROCEDURE Ablation Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01206452
The ClinicalTrials.gov registry entry for NCT01206452 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dhanunjaya Lakkireddy, MD, FACC, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01206452 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01206452 about?
NCT01206452 is a clinical study titled "Oral Steroids Before Pulmonary Vein Isolation to Improve Outcomes". The primary purpose of this study is to assess the efficacy of oral prednisone in improving the outcomes of pulmonary vein isolation with radiofrequency ablation.
What is the current status of trial NCT01206452?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 2010-09. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01206452?
The interventions under investigation include: Placebo (OTHER), Prednisone (DRUG), Ablation Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT01206452?
This trial is sponsored by Dhanunjaya Lakkireddy, MD, FACC, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.